Phibro Animal Health Corp Class A PAHC

Morningstar Rating
$35.62 −0.96 (2.62%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PAHC is trading at a LOCK|<NXMZ! premium.
Price
$35.60
Fair Value
LOCK|.%%b&?<
Uncertainty
LOCK|pd
1-Star Price
LOCK|.^&%fl<#
5-Star Price
LOCK|.TyKfs<
Economic Moat
LOCK|kWf
Capital Allocation

News

Trading Information

Previous Close Price
$36.58
Day Range
$35.5137.66
52-Week Range
$28.2560.08
Bid/Ask
$34.22 / $40.48
Shares Outstanding
40.60M
Market Cap
$1.45B
Volume/Avg
212,300 / 244,692

Key Statistics

Price/Earnings (Normalized)
11.10
Price/Sales
0.96
Dividend Yield (Trailing)
1.35%
Dividend Yield (Forward)
1.35%
Dividend Payment Schedule
Mar, Jun, Sep, Dec
Total Yield
1.35%

Company Profile

Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
2,605

Valuation

Metric
PAHC
Price/Earnings (Normalized)
11.10
Price/Book Value
3.75
Price/Sales
0.96
Price/Cash Flow
8.89
Price/Earnings
PAHC

Financial Strength

Metric
PAHC
Quick Ratio
1.01
Current Ratio
2.96
Interest Coverage
4.07
Quick Ratio
PAHC

Profitability

Metric
PAHC
Return on Assets (Normalized)
9.28%
Return on Equity (Normalized)
39.28%
Return on Invested Capital (Normalized)
14.56%
Return on Assets
PAHC

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|K%^%NH%kLOCK|T?%?$66B
Teva Pharmaceutical Industries Ltd ADR
TEVA
LOCK|!l&V$XZ^LOCK|d$Mc$43B
Haleon PLC ADR
HLN
LOCK|!FnkY^LOCK|@><$40B
Zoetis Inc Class A
ZTS
LOCK|y#p@L&scLOCK|#m$30B
Viatris Inc
VTRS
LOCK|N@?zBcLOCK|J@&$19B
Elanco Animal Health Inc
ELAN
LOCK|vj?LOCK|Pr^$12B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|gkzF^%LOCK|#nd$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|#rgg@&^LOCK|TPc$6B
Prestige Consumer Healthcare Inc
PBH
LOCK|hDcNh#LOCK|@!Tc$2B
Perrigo Co PLC
PRGO
LOCK|M&f>$@LOCK|@^#$2B

Sponsor Center